Citigroup
NERV icon

Citigroup’s Minerva Neurosciences NERV Stock Holding History

Citigroup’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.7K Buy
+15,973
New +$86.6K ﹤0.01% 4753
2025
Q4 		– Sell
-1
Closed -$2 – 6327
2025
Q3 		$2 Buy
+1
New +$2 ﹤0.01% 6024
2022
Q3 		– Sell
-2,125
Closed -$7K – 6162
2022
Q2 		$7K Buy
+2,125
New +$8.68K ﹤0.01% 5503
2021
Q3 		– Sell
-138
Closed -$3K – 6126
2021
Q2 		$3K Sell
138
-293
-68% -$6.31K ﹤0.01% 5925
2021
Q1 		$10K Sell
431
-539
-56% -$13.5K ﹤0.01% 5650
2020
Q4 		$18K Buy
970
+627
+183% +$15.8K ﹤0.01% 6720
2020
Q3 		$9K Sell
343
-350
-51% -$9.46K ﹤0.01% 6698
2020
Q2 		$20K Sell
693
-472
-41% -$27.7K ﹤0.01% 6610
2020
Q1 		$56K Buy
1,165
+298
+34% +$18K ﹤0.01% 5881
2019
Q4 		$49K Buy
867
+68
+9% +$3K ﹤0.01% 6325
2019
Q3 		$50K Sell
799
-458
-36% -$25.9K ﹤0.01% 6130
2019
Q2 		$57K Buy
1,257
+38
+3% +$1.9K ﹤0.01% 6348
2019
Q1 		$77K Buy
1,219
+228
+23% +$13.7K ﹤0.01% 5981
2018
Q4 		$53K Sell
991
-56
-5% -$4.1K ﹤0.01% 6188
2018
Q3 		$105K Buy
1,047
+398
+61% +$29.9K ﹤0.01% 5854
2018
Q2 		$43K Sell
649
-684
-51% -$41.5K ﹤0.01% 6395
2018
Q1 		$67K Buy
1,333
+15
+1% +$721 ﹤0.01% 5954
2017
Q4 		$63K Buy
1,318
+991
+303% +$49.1K ﹤0.01% 6011
2017
Q3 		$20K Sell
327
-31,306
-99% -$1.8M ﹤0.01% 6441
2017
Q2 		$2.24M Buy
31,633
+31,279
+8,836% +$2.02M ﹤0.01% 2472
2017
Q1 		$23K Sell
354
-881
-71% -$68.4K ﹤0.01% 6187
2016
Q4 		$116K Buy
1,235
+1,040
+533% +$106K ﹤0.01% 5685
2016
Q3 		$22K Sell
195
-7
-3% -$679 ﹤0.01% 6157
2016
Q2 		$16K Sell
202
-423
-68% -$26.9K ﹤0.01% 6283
2016
Q1 		$31K Sell
625
-1
-0.2% -$43 ﹤0.01% 6340
2015
Q4 		$30K Buy
+626
New +$26.1K ﹤0.01% 6263
2015
Q2 		– Sell
-105
Closed -$4K – 7663
2015
Q1 		$4K Buy
+105
New +$4.35K ﹤0.01% 6783
2014
Q4 		– Sell
-53
Closed -$3K – 7237
2014
Q3 		$3K Buy
+53
New +$2.82K ﹤0.01% 6731

Other funds holding NERV

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Citigroup's NERV Position: Q2 2026 in Review

Citigroup opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 15,973 shares worth $88.7K. The stake represents ﹤0.01% of the portfolio and ranks #4753 among its holdings. This is a return to the name: Citigroup previously reported a position in NERV as recently as Q3 2025.

Citigroup first reported a position in NERV in Q3 2014 and has held it in 28 quarters since. The position peaked at $2.24M in Q2 2017. 11 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Citigroup held 15,973 shares of Minerva Neurosciences worth $88.7K as of Q2 2026.
  • Minerva Neurosciences was a new Citigroup position in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4753 holding.
  • Citigroup first reported a position in Minerva Neurosciences in Q3 2014 and has held it in 28 quarters since.
  • Citigroup's Minerva Neurosciences position peaked at $2.24M in Q2 2017.
  • 11 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.